June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Adherence Capability of Cultivated Retinoblastoma Cells
Author Affiliations & Notes
  • Narges Fazili
    Ocular Tissue Engineering Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran (the Islamic Republic of)
  • Sahar Balagholi
    Ocular Tissue Engineering Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran, Tehran, Iran (the Islamic Republic of)
    Iran Blood Transfusion Organization, Tehran, Iran (the Islamic Republic of)
  • Mozhgan Rezaeikanavi
    Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran (the Islamic Republic of)
    Ocular Tissue Engineering Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran (the Islamic Republic of)
  • Somayeh Asadi
    Ocular Tissue Engineering Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran, Tehran, Iran (the Islamic Republic of)
    K.N.Toosi of Technology, Tehran, Iran (the Islamic Republic of)
  • Seyed Bagher Hosseini
    Central Eye Bank of Iran, Tehran, Iran (the Islamic Republic of)
  • Footnotes
    Commercial Relationships Narges Fazili, None; Sahar Balagholi, None; Mozhgan Rezaeikanavi, None; Somayeh Asadi, None; Seyed Bagher Hosseini, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 66. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Narges Fazili, Sahar Balagholi, Mozhgan Rezaeikanavi, Somayeh Asadi, Seyed Bagher Hosseini; Adherence Capability of Cultivated Retinoblastoma Cells. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):66.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

To investigate adherence capability of cultivated retinoblastoma (RB) tumorspheres with prolonged cultivation.

 
Methods
 

RB cells from two Iranian patients were cultivated in DMEM supplemented with 15% FBS for four weeks in each passage. Fresh medium was added on a weekly basis and immunocytochemistry for synaptophysin was performed. All the experiments were done in duplicate. Cell attachment capability was studied during three consecutive passages.

 
Results
 

A biphasic population of cultivated cells was observed during the first week in each passage; composed of RB tumorspheres and a single-cell suspension overlying a layer of fibroblastic cells that had adhered to the bottom of flask. Early adherence of RB tumorspheres to the bottom of flask, while surrounded by fibroblasts, was observed in the second week and increased by the fourth week (figure).

 
Conclusions
 

Compared to previous data, this study demonstrated the adherence capability of RB tumorspheres to the underlying surface with prolonged cultivation; which after 4 weeks seems to be independent of the fibroblasts.  

 
Figure: Cultivated retinoblastoma (RB) cells. A-B: Note the presence of RB tumorspheres (circle 1), single-cell suspension (circle 2) in the first week C-F: Cultivated RB cells in the second week: the circled area shows adhered RB tumorspheres; merged FITC synaptophysine expression and DAPI in cultivated RB cells (C), adhered RB tumorsphere (D), DAPI of nucleus of RB and fibroblast cells (E), merged FITC synaptophysine expression and DAPI in cultivated RB cells (F).
 
Figure: Cultivated retinoblastoma (RB) cells. A-B: Note the presence of RB tumorspheres (circle 1), single-cell suspension (circle 2) in the first week C-F: Cultivated RB cells in the second week: the circled area shows adhered RB tumorspheres; merged FITC synaptophysine expression and DAPI in cultivated RB cells (C), adhered RB tumorsphere (D), DAPI of nucleus of RB and fibroblast cells (E), merged FITC synaptophysine expression and DAPI in cultivated RB cells (F).

 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×